CAS RN: 51517-45-4
2-(11-HYDROXY-3-OXO-3H-DIBENZO[C,H]XANTHEN-7-YL)BENZOIC ACID
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250817 |
100mg / 250mg / 1g |
Out of stock |
5-7 business days | Inquiry |
-
Product code:
starshine_CAS51517-45-4
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
51517-45-4 / 2-(7-hydroxy-19-oxo-2-oxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(22),3(12),4(9),5,7,10,13,15,17,20-decaen-13-yl)benzoic acid
Standard CAS: 51517-45-4
Multi CAS: Yes
Basic Information
CAS
51517-45-4
Multi CAS
Yes
Molecular Formula
C28H16O5
Molecular Weight
432.400000
Exact Mass
432.099774
InChI
InChI=1S/C28H16O5/c29-17-7-11-19-15(13-17)5-9-23-25(21-3-1-2-4-22(21)28(31)32)24-10-6-16-14-18(30)8-12-20(16)27(24)33-26(19)23/h1-14,29H,(H,31,32)
InChIKey
LFZLBQHTPRXHSQ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
33
Aromatic heavy atom count
28
Rotatable bonds
2
H-bond acceptors
4
H-bond donors
2
Molar refractivity
129.06
TPSA
87.74
LogP / Solubility
WLOGP
6.32
MLOGP
5.59
XLogP3
4.1
Consensus LogP
5.34
Log S (ESOL)
-7
Class (ESOL)
Insoluble
Log S (Ali)
-7.67
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.96
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.87
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4